Fentanyl Patch Lawsuit Settlement Reached Over Fatal Overdose

A settlement has been reached by parties involved in a fentanyl patch lawsuit stemming from the fatal overdose of an Illinois man on the powerful painkiller. 

Leigh Ann Cruse filed the wrongful death lawsuit in Madison County Circuit Court against a number of fentanyl pain patch manufacturers in 2007, including Johnson & Johnson, Janssen Pharmaceutical Products, and Alza Corporation. Cruse alleged that the companies were responsible for the death of her husband, Cliff Cruse, who died in April 2006 from a fentanyl overdose after using the pain patches for about a month.

The lawsuit originally included Tri-City Neurology Associates Ltd. and Dr. Syed Ali of Granite City as defendants, however they were dismissed from the lawsuit last month, according to a story in the St. Clair Record.

Learn More About

Fentanyl Patch Lawsuits

The fentanyl patch contains a powerful fentanyl gel, which is 100-times stronger than morphine. The gel is supposed to be contained within the patch and delivered in a regulated fashion through a membrane placed on the skin. The original Duragesic patch was designed and distributed by Johnson & Johnson, but the pain patch is now available from a number of generic drug makers.

The FDA has received reports of hundreds of fentanyl overdoses and deaths associated with the use of the Duragesic patch and generic pain patches. The deaths have been caused when too much of the medication was delivered through the membrane or as a result of manufacturing defects which allowed the fentanyl gel to leak directly onto the skin.

Cruse’s lawsuit charged the defendants with strict product liability, negligence, breach of warranty, among other claims. The case was scheduled for trial to being on April 19, and the parties reached a settlement of the fentanyl patch lawsuit on April 9. Terms of the agreement have not been disclosed.

Out of the first four fentanyl patch wrongful death lawsuits against Johnson & Johnson to go to trial over problems with their Duragesic patch, plaintiffs have been successful in each case, with juries awarding a combined total of more than $36 million in damages.

1 Comments

  • DennisFebruary 29, 2012 at 5:22 pm

    I have been using the 100mg fentanyl patch for about 7 months now started on 50 mg then went to 75mg and because i was not getting pain relief the Dr. placed me on 100mg with a change every 72 hours.Although it has worded pretty well .,I have had days when i am completly in a daze. Braking out in sweats and just falling asleep every 10 minutes. I am seeing a new pain management Dr. and he has reco[Show More]I have been using the 100mg fentanyl patch for about 7 months now started on 50 mg then went to 75mg and because i was not getting pain relief the Dr. placed me on 100mg with a change every 72 hours.Although it has worded pretty well .,I have had days when i am completly in a daze. Braking out in sweats and just falling asleep every 10 minutes. I am seeing a new pain management Dr. and he has recommended that i have a neurostimulation placed in my body. I have been on pain meds for over 5 years., Because of nerve damage caused bu 76 radation treatment in the course of one year due to the treatment of two separete cancers and the doctors say i will have to live with this pain for the rest of my life. I am 66 years old

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Depo-Provera Brain Tumor Warnings Added to Drug Label in Europe, But Not In U.S.
Depo-Provera Brain Tumor Warnings Added to Drug Label in Europe, But Not In U.S. (Posted yesterday)

A recently filed Depo-Provera lawsuit questions why Pfizer updated the drug label in Europe, to warn about the risk of meningioma brain tumors, but failed to provide the same Depo-Provera warnings to U.S. consumers and doctors.

Hair Relaxer Lawsuit Status Conference To Be Held With MDL Judge This Week
Hair Relaxer Lawsuit Status Conference To Be Held With MDL Judge This Week (Posted 3 days ago)

U.S. District Judge presiding over all federal hair relaxer lawsuits will meet with lawyers involved in the litigation on Thursday, to discuss the status of the claims and when to move forward with bellwether cases.